Circulating eNAMPT in Glaucoma: A Semi-Quantitative Plasma Analysis Before and After Nicotinamide Supplementation | Synapse
March 3, 2026Open Access
Circulating eNAMPT in Glaucoma: A Semi-Quantitative Plasma Analysis Before and After Nicotinamide Supplementation
Key Points
Plasma eNAMPT levels enable sensitive detection, providing insights into glaucoma mechanisms and potential biomarkers.
Results indicate a distinct pattern of circulating eNAMPT before and after nicotinamide supplementation in glaucoma patients.
Assessment involved a semi-quantitative analysis of plasma samples from glaucoma patients and controls.
This analysis highlights the potential for eNAMPT as a biomarker, yet further validation is required before clinical application.
Abstract
This study established a method to sensitively detect plasma eNAMPT of patients with glaucoma and controls, providing a basis for future biomarker development.
Like
Bookmark
Share
View Full Paper
Like
Bookmark
Share
View Full Paper
Cite This Study
Vallbona-Garcia et al. (Wed,) studied this question.